SCHEMBL6170855

SCHEMBL6170855

CC(C)(C)[SiH2]OC(c1ccccc1)(c1ccccc1)c1cc(C=O)cc(C(=O)O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UNG P13051 1/20 0.40
ALDH1A1 P00352 2/20 0.34
TRIM24 O15164 1/20 0.33
TRIM33 Q9UPN9 1/20 0.33
ALOX15 P16050 2/20 0.33
RXRA P19793 2/20 0.33
RXRB P28702 2/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
BLM P54132 1/20 0.33
CASP7 P55210 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MAOB P27338 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
SRD5A2 P31213 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9837406 0.81 ALDH1A1 (0.37) UNGALDH1A1TRIM24TRIM33ALOX15
SCHEMBL6170678 0.81 TSHR (0.41) ALDH1A1MAPTMAPK1
SCHEMBL7451104 0.80 UNG (0.36) UNGALDH1A1TRIM24TRIM33TP53
SCHEMBL6172247 0.80 PRKCA (0.38) RXRARXRBTP53MAPTSMN1; SMN2
SCHEMBL9837387 0.75 KIF11 (0.45) MAPTMAOBMEN1KMT2ACES1
SCHEMBL1315596 0.74 MAPK1 (0.44) ALDH1A1ALOX15CYP3A4MAPTMAPK1
SCHEMBL10544293 0.73 SMN1; SMN2 (0.50) UNGALDH1A1TRIM24TRIM33ALOX15
SCHEMBL5918967 0.73 HPGD (0.45) ALDH1A1MAPTSMN1; SMN2TDP1MAOB
SCHEMBL1587498 0.72 ALDH1A1 (0.33) ALDH1A1MAPK1
SCHEMBL2997840 0.70 CES2 (0.48) UNGALDH1A1TRIM24TRIM33RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1192127-B1 SUBSTITUTED BENZAMIDE INHIBITORS OF RHINOVIRUS 3C PROTEASE AGOURON PHARMA (US) 2005-03-30 EP disclosed